Earlier

 May 2012 
MonTueWedThuFriSatSun
 
4
5
6
11
12
13
18
19
20
25
26
27
28
   
 June 2012 
MonTueWedThuFriSatSun
    
1
9
10
15
16
23
24
28
29
30
 
 July 2012 
MonTueWedThuFriSatSun
      
1
2
4
5
6
7
8
9
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
     

Later

RSS

Event

Good Clinical Practices (GCPs)

March 19, 2012, March 20, 2012, March 21, 2012 iCal


Location: Berlin, Germany

Course Description:

This is a three-day course designed to provide individuals with an in-depth understanding of the clinical research process, the roles and responsibilities of key players, as well as, regulatory requirements. The course consists of lecture and exercises. Participants will also be placed in several real life situations such as reviewing pre-study documents and informed consent forms for completeness and compliance; conducting drug accountability; reviewing case report forms for accuracy and adherence to protocol and performing source document verification.

The course is designed to provide the attendee with thorough knowledge of the following topics:

  • How drugs are discovered and developed for marketing approval
  • The four different study phases of clinical research
  • What constitutes Good Clinical Practices (GCP)
  • The principles of ICH GCP
  • The IRB/IEC’s composition and role/responsibilities
  • The IRB study review & approval process
  • The role and responsibilities of the investigator & study site staff
  • The role and responsibility of the sponsor
  • The history of the FDA and their role & responsibilities
  • Which sections of 21 CFR govern conduct of clinical studies
  • The purpose for an IND and its composition
  • How INDs are filed, reviewed, approved & amended
  • The IND reporting requirements
  • The requirements for Informed Consent
  • How to review an Informed Consent form for compliance
  • The process for Informed Consent review & approval
  • The administration of subjects Informed Consent
  • The different types of study Monitoring visits & tasks for each
  • Adverse Events - the types and reporting requirements
  • How to perform Drug Accountability & compliance
  • How to manage study supplies
  • How to detect and deal with Fraud
  • The purpose and composition of the NDA
  • How NDAs are filed, reviewed and approved
  • Sponsor responsibilities after approval
  • How to review study documents & determine compliance
  • How to review Case Report Forms and determine adherence to protocol
  • How to perform Source Document Verification

For more information please visit: http://www.cfpie.com/showitem.aspx?productid=039&source=lsam


Back